Log In
Print this Print this

Venclexta, Venclyxto, venetoclax (ABT-199, RG7601) (formerly GDC-0199)

  Manage Alerts
Collapse Summary General Information
Company Roche
DescriptionSmall molecule B cell lymphoma 2 (BCL-2; BCL2) inhibitor
Molecular Target B cell lymphoma 2 (BCL-2) (BCL2)
Mechanism of ActionBcl-2 inhibitor
Therapeutic ModalitySmall molecule

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today